Compare CHE & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHE | GRFS |
|---|---|---|
| Founded | 1970 | 1940 |
| Country | United States | Spain |
| Employees | N/A | 25247 |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.8B |
| IPO Year | 1994 | N/A |
| Metric | CHE | GRFS |
|---|---|---|
| Price | $399.18 | $8.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $498.00 | $10.15 |
| AVG Volume (30 Days) | 229.2K | ★ 699.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 0.60% | ★ 1.77% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 18.34 | N/A |
| Revenue | ★ $2,529,978,000.00 | N/A |
| Revenue This Year | $6.60 | $5.33 |
| Revenue Next Year | $6.15 | $6.50 |
| P/E Ratio | $21.92 | ★ $18.67 |
| Revenue Growth | ★ 4.06 | N/A |
| 52 Week Low | $385.00 | $6.19 |
| 52 Week High | $623.61 | $11.14 |
| Indicator | CHE | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 34.96 | 34.22 |
| Support Level | $385.00 | $7.64 |
| Resistance Level | $462.68 | $9.11 |
| Average True Range (ATR) | 12.45 | 0.28 |
| MACD | -2.45 | -0.09 |
| Stochastic Oscillator | 35.58 | 17.96 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.